PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

NAActive, not recruitingINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

December 11, 2023

Study Completion Date

December 6, 2029

Conditions
Acute Aortic Dissection
Interventions
DEVICE

AMDS

AMDS Implantation

Trial Locations (25)

10029

Mount Sinai Hospital, New York

10032

Columbia University Irving Medical Center/New York Presbyterian Hospital, New York

10075

Northwell, New York

10467

Montefiore Einstein Medical, The Bronx

15232

University of Pittsburgh Medical Center, Pittsburgh

19096

Lankenau Medical Center, Wynnewood

19104

University of Pennsylvania, Philadelphia

28203

Atrium Health Carolinas Medical Center, Charlotte

29425

Medical University of South Carolina, Charleston

30322

Emory University Medical Center, Atlanta

32610

University of Florida, Gainesville

35294

University of Alabama at Birmingham, Birmingham

44195

Cleveland Clinic Foundation, Cleveland

48109

University of Michigan, Ann Arbor

60611

Northwestern University, Chicago

63130

Washington University in St. Louis, St Louis

75093

Baylor Scott & White The Heart Hospital Plano, Plano

77030

Baylor College of Medicine/ St. Luke's Medical Center, Houston

78723

Ascension Seton/University of Texas, Austin

80045

University of Colorado, Aurora

90033

University of Southern California, Los Angeles

94035

Stanford University, Palo Alto

97239

Oregon Health and Science University, Portland

06102

Hartford Hospital, Hartford

02115

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Artivion Inc.

INDUSTRY